Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response

Identifieur interne : 001D04 ( Main/Exploration ); précédent : 001D03; suivant : 001D05

Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response

Auteurs : Takashi Tomoda [États-Unis] ; Hideo Morita [États-Unis] ; Takanobu Kurashige [États-Unis] ; Hunein F. Maassab [États-Unis]

Source :

RBID : ISTEX:A29E5FF5D88DFDA97C91FC301EC44CFA1A60B16E

English descriptors

Abstract

Abstract: To clarify which immunological factors were more effective in preventing influenza virus infection, we measured immunological parameters induced by vaccination and infection in vivo and in vitro. Healthy adult subjects (n = 128) were divided into vaccinated (n = 85) and untreated (n = 43) groups. Eighty-five were vaccinated intranasally with a trivalent cold-adapted recombinant influenza virus vaccine containing type A (H1N1 and H3N2) and B viruses. Subjects were mostly seropositive before vaccination. In 29 (80.6%) of the 36 examinees showing a prevaccination HI antibody titre of less than 1:128, the titre increased more than four times after vaccination. On the other hand, an increase of more than four times was found in four (8.2%) of the 49 individuals who had shown a prevaccination titre of more than 1:128. The IgA antibody was negligibly detected in the nasal wash specimens before vaccination, and was induced by vaccination in some cases. Lymphocyte proliferation and interleukin 2 (IL-2) production in cultured lymphocytes of the same subjects stimulated by H1N1 virus in vitro were correlated with the HI antibody titre. However, the interferon γ (IFN-γ) production was low before vaccination, regardless of the HI antibody titre, and showed a significant increase after vaccination. It was suggested that local IgA response and IFN-γ production play important roles in the prevention of influenza. Since there was the outbreak of influenza A (H1N1) in Kochi Prefecture after completion of blood samples 6–8 weeks after the second vaccination, we examined the above hypothesis. A significantly (p<0.01) lower morbidity rate in the vaccinated examinees was found. The HI antibody, lymphocyte DNA synthesis and IL-2 production, which had been increased by vaccination, showed little further increase in response to the epidemic. In contrast, local IgA response and IFN-γ production, which had been increased by vaccination, showed another increase because of the epidemc.

Url:
DOI: 10.1016/0264-410X(95)93134-U


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response</title>
<author>
<name sortKey="Tomoda, Takashi" sort="Tomoda, Takashi" uniqKey="Tomoda T" first="Takashi" last="Tomoda">Takashi Tomoda</name>
</author>
<author>
<name sortKey="Morita, Hideo" sort="Morita, Hideo" uniqKey="Morita H" first="Hideo" last="Morita">Hideo Morita</name>
</author>
<author>
<name sortKey="Kurashige, Takanobu" sort="Kurashige, Takanobu" uniqKey="Kurashige T" first="Takanobu" last="Kurashige">Takanobu Kurashige</name>
</author>
<author>
<name sortKey="Maassab, Hunein F" sort="Maassab, Hunein F" uniqKey="Maassab H" first="Hunein F." last="Maassab">Hunein F. Maassab</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A29E5FF5D88DFDA97C91FC301EC44CFA1A60B16E</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1016/0264-410X(95)93134-U</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-X7L6SPWB-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C15</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C15</idno>
<idno type="wicri:Area/Istex/Curation">000C15</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A79</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A79</idno>
<idno type="wicri:doubleKey">0264-410X:1995:Tomoda T:prevention:of:influenza</idno>
<idno type="wicri:Area/Main/Merge">001D78</idno>
<idno type="wicri:Area/Main/Curation">001D04</idno>
<idno type="wicri:Area/Main/Exploration">001D04</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response</title>
<author>
<name sortKey="Tomoda, Takashi" sort="Tomoda, Takashi" uniqKey="Tomoda T" first="Takashi" last="Tomoda">Takashi Tomoda</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morita, Hideo" sort="Morita, Hideo" uniqKey="Morita H" first="Hideo" last="Morita">Hideo Morita</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kurashige, Takanobu" sort="Kurashige, Takanobu" uniqKey="Kurashige T" first="Takanobu" last="Kurashige">Takanobu Kurashige</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Maassab, Hunein F" sort="Maassab, Hunein F" uniqKey="Maassab H" first="Hunein F." last="Maassab">Hunein F. Maassab</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1995">1995</date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="185">185</biblScope>
<biblScope unit="page" to="190">190</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antibody</term>
<term>Antibody response</term>
<term>Cultured lymphocytes</term>
<term>Examinee</term>
<term>Healthy adults</term>
<term>Hlnl</term>
<term>Hlnl virus</term>
<term>Immunological factors</term>
<term>Important role</term>
<term>Important roles</term>
<term>Influenza</term>
<term>Influenza cytotoxic</term>
<term>Influenza epidemics</term>
<term>Influenza infection</term>
<term>Influenza vaccine</term>
<term>Influenza virus</term>
<term>Influenza virus vaccine</term>
<term>Intranasal administration</term>
<term>Kochi</term>
<term>Kochi prefecture</term>
<term>Lower morbidity rate</term>
<term>Lymphocyte</term>
<term>Lymphocyte activation</term>
<term>Lymphocyte proliferation</term>
<term>Lymphocyte proliferation assay</term>
<term>Nasal</term>
<term>Nasal wash specimen</term>
<term>Nasal wash specimens</term>
<term>Questionnaire survey</term>
<term>Saliva samples</term>
<term>Second vaccination</term>
<term>Significant change</term>
<term>Significant increase</term>
<term>Stimulation index</term>
<term>Untreated groups</term>
<term>Untreated ones</term>
<term>Vaccinated</term>
<term>Vaccinated examinees</term>
<term>Vaccinated individuals</term>
<term>Vaccinated students</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Virus</term>
<term>Virus infection</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: To clarify which immunological factors were more effective in preventing influenza virus infection, we measured immunological parameters induced by vaccination and infection in vivo and in vitro. Healthy adult subjects (n = 128) were divided into vaccinated (n = 85) and untreated (n = 43) groups. Eighty-five were vaccinated intranasally with a trivalent cold-adapted recombinant influenza virus vaccine containing type A (H1N1 and H3N2) and B viruses. Subjects were mostly seropositive before vaccination. In 29 (80.6%) of the 36 examinees showing a prevaccination HI antibody titre of less than 1:128, the titre increased more than four times after vaccination. On the other hand, an increase of more than four times was found in four (8.2%) of the 49 individuals who had shown a prevaccination titre of more than 1:128. The IgA antibody was negligibly detected in the nasal wash specimens before vaccination, and was induced by vaccination in some cases. Lymphocyte proliferation and interleukin 2 (IL-2) production in cultured lymphocytes of the same subjects stimulated by H1N1 virus in vitro were correlated with the HI antibody titre. However, the interferon γ (IFN-γ) production was low before vaccination, regardless of the HI antibody titre, and showed a significant increase after vaccination. It was suggested that local IgA response and IFN-γ production play important roles in the prevention of influenza. Since there was the outbreak of influenza A (H1N1) in Kochi Prefecture after completion of blood samples 6–8 weeks after the second vaccination, we examined the above hypothesis. A significantly (p<0.01) lower morbidity rate in the vaccinated examinees was found. The HI antibody, lymphocyte DNA synthesis and IL-2 production, which had been increased by vaccination, showed little further increase in response to the epidemic. In contrast, local IgA response and IFN-γ production, which had been increased by vaccination, showed another increase because of the epidemc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Michigan</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Michigan">
<name sortKey="Tomoda, Takashi" sort="Tomoda, Takashi" uniqKey="Tomoda T" first="Takashi" last="Tomoda">Takashi Tomoda</name>
</region>
<name sortKey="Kurashige, Takanobu" sort="Kurashige, Takanobu" uniqKey="Kurashige T" first="Takanobu" last="Kurashige">Takanobu Kurashige</name>
<name sortKey="Maassab, Hunein F" sort="Maassab, Hunein F" uniqKey="Maassab H" first="Hunein F." last="Maassab">Hunein F. Maassab</name>
<name sortKey="Morita, Hideo" sort="Morita, Hideo" uniqKey="Morita H" first="Hideo" last="Morita">Hideo Morita</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D04 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D04 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A29E5FF5D88DFDA97C91FC301EC44CFA1A60B16E
   |texte=   Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021